info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N014791 |
| CAS No | NA |
| Mol.F. | C9H14N6O4 |
| Mol.Wt. | 270.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014792 |
| CAS No | 1355024-07-5 |
| Mol.F. | C9H14N6O4 |
| Mol.Wt. | 270.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014793 |
| CAS No | NA |
| Mol.F. | C6H7N7O3 |
| Mol.Wt. | 225.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014794 |
| CAS No | NA |
| Mol.F. | C6H8N6O2 |
| Mol.Wt. | 196.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014795 |
| CAS No | NA |
| Mol.F. | C6H8N6O2 |
| Mol.Wt. | 196.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014796 |
| CAS No | NA |
| Mol.F. | C9H14N6O4 : HCl |
| Mol.Wt. | 270.2 : 36.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014797 |
| CAS No | NA |
| Mol.F. | C9H14N6O4 : HCl |
| Mol.Wt. | 270.2 : 36.5 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014798 |
| CAS No | NA |
| Mol.F. | C9H13N7O5 |
| Mol.Wt. | 299.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014799 |
| CAS No | NA |
| Mol.F. | C9H12N6O4 |
| Mol.Wt. | 268.2 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014800 |
| CAS No | NA |
| Mol.F. | C20H14BrN7O2 |
| Mol.Wt. | 464.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014801 |
| CAS No | NA |
| Mol.F. | C21H35N9O6 |
| Mol.Wt. | 509.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014802 |
| CAS No | NA |
| Mol.F. | C22H35N9O4 |
| Mol.Wt. | 489.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014803 |
| CAS No | NA |
| Mol.F. | C29H38N6O9 |
| Mol.Wt. | 614.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014804 |
| CAS No | NA |
| Mol.F. | C28H36N6O9 |
| Mol.Wt. | 600.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014805 |
| CAS No | NA |
| Mol.F. | C28H36N6O9 |
| Mol.Wt. | 600.6 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014806 |
| CAS No | NA |
| Mol.F. | C12H7ClN2OS |
| Mol.Wt. | 262.7 |
| INV STATUS | CUSTOM SYNTHESIS |
